Efficacy, Tolerance, and Plasma Levels of Abiraterone and Its Main Metabolites in a Patient With Metastatic Castration-resistant Prostate Cancer With a Hepatic Transplant.

More about this publication

Clinical genitourinary cancer
  • Volume 17
  • Issue nr. 5
  • Pages e893-e896
  • Publication date 01-10-2019

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.